127 related articles for article (PubMed ID: 21542975)
41. An overview of new biomolecular pathways in pathogen-related cancers.
Tornesello ML; Buonaguro L; Buonaguro FM
Future Oncol; 2015; 11(11):1625-39. PubMed ID: 26043216
[TBL] [Abstract][Full Text] [Related]
42. Tumors arise from the excessive repair of damaged stem cells.
Li JW; Yang D; Yang D; Chen Z; Miao J; Liu W; Wang X; Qiu Z; Jin M; Shen Z
Med Hypotheses; 2017 May; 102():112-122. PubMed ID: 28478815
[TBL] [Abstract][Full Text] [Related]
43. Formation of benign tumors by stem cell deregulation.
Valet M; Narbonne P
PLoS Genet; 2022 Oct; 18(10):e1010434. PubMed ID: 36301803
[TBL] [Abstract][Full Text] [Related]
44. Cancer associated fibroblasts in cancer pathogenesis.
Franco OE; Shaw AK; Strand DW; Hayward SW
Semin Cell Dev Biol; 2010 Feb; 21(1):33-9. PubMed ID: 19896548
[TBL] [Abstract][Full Text] [Related]
45. Apoptotic Switch in Cancer Stem Cells: A Potential Approach for Cancer Treatment.
Gunasekaran VP; Sivaraman T; Ganeshan M
Curr Protein Pept Sci; 2023; 24(10):843-852. PubMed ID: 37183463
[TBL] [Abstract][Full Text] [Related]
46. Feedback Regulation in a Cancer Stem Cell Model can Cause an Allee Effect.
Konstorum A; Hillen T; Lowengrub J
Bull Math Biol; 2016 Apr; 78(4):754-785. PubMed ID: 27113934
[TBL] [Abstract][Full Text] [Related]
47. Autonomy in tumor cell proliferation.
Chigira M; Noda K; Watanabe H
Med Hypotheses; 1990 Aug; 32(4):249-54. PubMed ID: 2172752
[TBL] [Abstract][Full Text] [Related]
48. Cancer as an endocrine problem.
Holly JM; Perks CM
Best Pract Res Clin Endocrinol Metab; 2008 Aug; 22(4):539-50. PubMed ID: 18971117
[TBL] [Abstract][Full Text] [Related]
49. Cancer and stem cell signaling: a guide to preventive and therapeutic strategies for cancer stem cells.
Sell S
Stem Cell Rev; 2007 Jan; 3(1):1-6. PubMed ID: 17873376
[No Abstract] [Full Text] [Related]
50. Cancer: A turbulence problem.
Uthamacumaran A
Neoplasia; 2020 Dec; 22(12):759-769. PubMed ID: 33142240
[TBL] [Abstract][Full Text] [Related]
51. The invasion of de-differentiating cancer cells into hierarchical tissues.
Zhou D; Luo Y; Dingli D; Traulsen A
PLoS Comput Biol; 2019 Jul; 15(7):e1007167. PubMed ID: 31260442
[TBL] [Abstract][Full Text] [Related]
52. Theranostic Platforms Proposed for Cancerous Stem Cells: A Review.
Zarrintaj P; Mostafapoor F; Milan PB; Saeb MR
Curr Stem Cell Res Ther; 2019; 14(2):137-145. PubMed ID: 30280678
[TBL] [Abstract][Full Text] [Related]
53. Determinants of nutrient limitation in cancer.
Sullivan MR; Vander Heiden MG
Crit Rev Biochem Mol Biol; 2019 Jun; 54(3):193-207. PubMed ID: 31162937
[TBL] [Abstract][Full Text] [Related]
54. Evolving models of tumor origin and progression.
Mitrus I; Bryndza E; Sochanik A; Szala S
Tumour Biol; 2012 Aug; 33(4):911-7. PubMed ID: 22492238
[TBL] [Abstract][Full Text] [Related]
55. Nutritional and signal interactions in a tumor-host social relationship.
Lou MQ; Huang Q; Zhao YD
Chin Med J (Engl); 2011 Aug; 124(15):2400. PubMed ID: 21933576
[No Abstract] [Full Text] [Related]
56. [Identification, modeling and simulation of key pathways underlying certain cancers].
Guo H; Zhu YP; Li D; He FC
Yi Chuan; 2011 Aug; 33(8):809-19. PubMed ID: 21831798
[TBL] [Abstract][Full Text] [Related]
57. How the growth rate of host cells affects cancer risk in a deterministic way.
Draghi C; Viger L; Denis F; Letellier C
Chaos; 2017 Sep; 27(9):093101. PubMed ID: 28964154
[TBL] [Abstract][Full Text] [Related]
58. Biochemistry of the cancer cell.
Pawson T
Curr Opin Oncol; 1990 Feb; 2(1):143-51. PubMed ID: 2095222
[No Abstract] [Full Text] [Related]
59. Essence of resistance to anti-angiogenic therapy in tumors.
Chen ZP
Chin Med J (Engl); 2011 Dec; 124(24):4363. PubMed ID: 22340416
[No Abstract] [Full Text] [Related]
60. Animals and Transmissible Cancers: Evidence Grows.
Sindzinski A
J Natl Cancer Inst; 2016 Nov; 108(11):. PubMed ID: 27920055
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
